Cancer News and Research

Latest Cancer News and Research

Still River Systems announces clinical beam extraction from world's smallest high-energy proton therapy accelerator

Still River Systems, Inc. announces successful clinical beam extraction from the first production unit of the world's smallest high-energy proton therapy accelerator. Powerful proton beams are used for the precise treatment of cancer by delivering a highly focused beam of radiation to the tumor while reducing the damage to surrounding healthy tissue and vital organs.

15 May 2010

Neogenix awarded Emerging Company of the Year by TCM

Neogenix Oncology, Inc., announced today that they were awarded "Emerging Company of the Year" by The Tech Council of Maryland, the state's largest technology trade association at its 22nd Annual Tech Awards including more than 800 technology and business leaders from around the region.

15 May 2010

Agronomic practices can increase cancer-preventive phytochemicals in broccoli and tomatoes

A University of Illinois study has demonstrated that agronomic practices can greatly increase the cancer-preventive phytochemicals in broccoli and tomatoes.

15 May 2010

National study of factors related to unmet health needs among homeless people

The vast majority of homeless adults surveyed in a national study had trouble accessing at least one type of needed health care service in the preceding year, according to a study that will appear in the July American Journal of Public Health and is now available online.

15 May 2010

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).

15 May 2010

U.S. healthcare practitioners can resume use of Rotarix, says FDA

GlaxoSmithKline announced that the Food and Drug Administration has determined that U.S. healthcare practitioners can resume the use of Rotarix (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and reflects the agency's assessment that the presence of porcine circovirus type 1 in the vaccine poses no safety risk.

15 May 2010

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has classified the OFIRMEV™ (acetaminophen) injection New Drug Application (NDA) resubmission as a complete Class 2 response to the FDA's February 10, 2010 action letter and assigned a new Prescription Drug User Fee Act (PDUFA) action date of November 4, 2010.

15 May 2010

Oxygen levels induce X chromosome inactivation in female cells: Study

Oxygen levels in the lab can permanently alter human embryonic stem (ES) cells, specifically inducing X chromosome inactivation in female cells, according to Whitehead Institute researchers. Human ES cells have been routinely created and maintained at atmospheric levels of oxygen, which is about 20%. Cells in the body are usually exposed to only 1-9% oxygen.

14 May 2010

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

BioSante Pharmaceuticals, Inc. today reported on its recent developments and financial results for the first quarter, and its cash balance as of March 31, 2010.

14 May 2010

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.

14 May 2010

American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter of 2010.

14 May 2010

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.

14 May 2010

New initiative to reduce health inequities

A major new initiative by the University of Maryland aims to eliminate health disparities in the state and extend the impact of health reform. The university's School of Public Health has recruited a team of nationally recognized faculty-researchers who will create action programs to improve primary care and expand public health outreach, so as to reduce the high rates of chronic disease in Maryland's medically underserved communities.

14 May 2010

ATCC unveils new brand identity

ATCC, the premier biomaterials resource and standards organization, today proudly unveiled its new brand initiative. The fresh identity is a bold and confident logotype featuring the brand promise—THE ESSENTIALS OF LIFE SCIENCE RESEARCH. GLOBALLY DELIVERED.™ The new brand promise is an accurate reflection of ATCC's multiple offerings and global distribution network. Launch of the rebrand will bring focus to ATCC's extended capabilities as a reagents and tools company in support of life science research.

14 May 2010

Medtronic releases Virtual ICD study data

Medtronic, Inc. released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients would be free of inappropriate shocks one year after implant and 92 percent at five years post-implant.

14 May 2010

Study examines impact of tobacco smoke carcinogen on mice

Although tobacco use is widely understood to be one of the leading causes of oral cancer, research on the prevention of tobacco-related oral cancer in experimental animals has traditionally been limited to examining the impact of synthetic carcinogens manufactured especially for cancer research, rather than on observing the effects of carcinogens that occur in tobacco smoke.

14 May 2010

Researchers determine how cells regulate chromosome/microtubule interface

Whitehead Institute researchers have determined a key part of how cells regulate the chromosome/microtubule interface, which is central to proper chromosomal distribution during cell division.

14 May 2010

RMEI, PIM sponsor continuing education series on castration-resistant prostate cancer

Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.

14 May 2010

New research to improve treatment for oesophageal and upper stomach cancer

Poor diet, too much alcohol, smoking and increasing obesity could be leading to an epidemic of oesophageal and upper stomach cancer, according to a leading UK team of specialists at The University of Nottingham and Nottingham University Hospitals.

14 May 2010

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

New data from a multi-centric international registry study show that cellular-level imaging with Mauna Kea Technologies' Cellvizio®, the world's smallest microscope, appears to significantly improve a physician's ability to diagnose or rule out early forms of bile duct cancer during a standard endoscopic diagnostic exam.

14 May 2010

Cancer News and Research

Latest Cancer News and Research

Still River Systems announces clinical beam extraction from world's smallest high-energy proton therapy accelerator

Neogenix awarded Emerging Company of the Year by TCM

Agronomic practices can increase cancer-preventive phytochemicals in broccoli and tomatoes

National study of factors related to unmet health needs among homeless people

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

U.S. healthcare practitioners can resume use of Rotarix, says FDA

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

Oxygen levels induce X chromosome inactivation in female cells: Study

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

New initiative to reduce health inequities

ATCC unveils new brand identity

Medtronic releases Virtual ICD study data

Study examines impact of tobacco smoke carcinogen on mice

Researchers determine how cells regulate chromosome/microtubule interface

RMEI, PIM sponsor continuing education series on castration-resistant prostate cancer

New research to improve treatment for oesophageal and upper stomach cancer

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in